Dabigatran results similar to warfarin in diabetes with NVAF

Patients with nonvalvular atrial fibrillation (NAVF) who also have diabetes experienced similar safety and efficacy with dabigatran relative to warfarin, in comparison without diabetes who have NVAF.

Related Videos
Dr. Charles Lee
© 2023 MJH Life Sciences

All rights reserved.